{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:09:52Z","timestamp":1707523792919},"reference-count":18,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,4,22]]},"DOI":"10.7759\/cureus.14624","type":"journal-article","created":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T12:10:15Z","timestamp":1619093415000},"source":"Crossref","is-referenced-by-count":0,"title":["Evolution of Knowledge in the Treatment of Long-Standing Atrial Fibrillation in a UK Tennis Champion"],"prefix":"10.7759","author":[{"given":"Shiv","family":"Krishnaswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manas","family":"Rane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Michael","family":"Gaziano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go AS","year":"2001","unstructured":"Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study. JAMA. 2001, 285:2370-5. 10.1001\/jama.285.18.2370","journal-title":"JAMA"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehi825","article-title":"Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study","volume":"27","author":"Heeringa J","year":"2006","unstructured":"Heeringa J, van der Kuip DA, Hofman A, et al.. Prevalence, incidence and lifetime risk of atrial fibrillation: the Rotterdam study. Eur Heart J. 2006, 27:949-53. 10.1093\/eurheartj\/ehi825","journal-title":"Eur Heart J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000665","article-title":"2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons","volume":"140","author":"January CT","year":"2019","unstructured":"January CT, Wann LS, Calkins H, et al.. 2019 AHA\/ACC\/HRS Focused Update of the 2014 AHA\/ACC\/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society in Collaboration With the Society of Thoracic Surgeons. Circulation. 2019, 140:e125-51. 10.1161\/CIR.0000000000000665","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof P","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, et al.. 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J. 2016, 37:2893-962. 10.1093\/eurheartj\/ehw210","journal-title":"Eur Heart J"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.09.024","article-title":"Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score","volume":"57","author":"Lip GY","year":"2011","unstructured":"Lip GY, Frison L, Halperin JL, Lane DA. Comparative validation of a novel risk score for predicting bleeding risk in anticoagulated patients with atrial fibrillation: the HAS-BLED (Hypertension, Abnormal Renal\/Liver Function, Stroke, Bleeding History or Predisposition, Labile INR, Elderly, Drugs\/Alcohol Concomitantly) score. J Am Coll Cardiol. 2011, 57:173-80. 10.1016\/j.jacc.2010.09.024","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1186\/s12992-019-0497-3","article-title":"A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications","volume":"15","author":"Baxi SM","year":"2019","unstructured":"Baxi SM, Beall R, Yang J, Mackey TK. A multidisciplinary review of the policy, intellectual property rights, and international trade environment for access and affordability to essential cancer medications. Global Health. 2019, 15:57. 10.1186\/s12992-019-0497-3","journal-title":"Global Health"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.312.7035.912","article-title":"Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata","volume":"312","author":"Hollman A","year":"1996","unstructured":"Hollman A. Drugs for atrial fibrillation. Digoxin comes from Digitalis lanata. BMJ. 1996, 312:912. 10.1136\/bmj.312.7035.912","journal-title":"BMJ"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa612","article-title":"2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"42","author":"Hindricks G","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, et al.. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2021, 42:373-498. 10.1093\/eurheartj\/ehaa612","journal-title":"Eur Heart J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.2.5367.1230","article-title":"Beta-adrenergic receptor blockade in cardiac arrhythmias","volume":"2","author":"Stock JP","year":"1963","unstructured":"Stock JP, Dale N. Beta-adrenergic receptor blockade in cardiac arrhythmias. Br Med J. 1963, 2:1230-3. 10.1136\/bmj.2.5367.1230","journal-title":"Br Med J"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196508192730802","article-title":"Effects of beta-adrenergic blockade with propranolol in patients with atrial arrhythmias","volume":"273","author":"Harrison DC","year":"1965","unstructured":"Harrison DC, Griffin JR, Fiene TJ. Effects of beta-adrenergic blockade with propranolol in patients with atrial arrhythmias. N Engl J Med. 1965, 273:410-5. 10.1056\/NEJM196508192730802","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5922.2009.00123.x","article-title":"Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents","volume":"28","author":"Cordero A","year":"2010","unstructured":"Cordero A, Bertomeu-Mart\u00ednez V, Maz\u00f3n P, F\u00e1cila L, Bertomeu-Gonz\u00e1lez V, Conthe P, Gonz\u00e1lez-Juanatey JR. Erectile dysfunction in high-risk hypertensive patients treated with beta-blockade agents. Cardiovasc Ther. 2010, 28:15-22. 10.1111\/j.1755-5922.2009.00123.x","journal-title":"Cardiovasc Ther"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021328","article-title":"A comparison of rate control and rhythm control in patients with atrial fibrillation","volume":"347","author":"Wyse DG","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, et al.. A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med. 2002, 347:1825-33. 10.1056\/NEJMoa021328","journal-title":"N Engl J Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021375","article-title":"A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation","volume":"347","author":"Van Gelder IC","year":"2002","unstructured":"Van Gelder IC, Hagens VE, Bosker HA, et al.. A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med. 2002, 347:1834-40. 10.1056\/NEJMoa021375","journal-title":"N Engl J Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(03)00332-2","article-title":"Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study","volume":"41","author":"Carlsson J","year":"2003","unstructured":"Carlsson J, Miketic S, Windeler J, et al.. Randomized trial of rate-control versus rhythm-control in persistent atrial fibrillation: the Strategies of Treatment of Atrial Fibrillation (STAF) study. J Am Coll Cardiol. 2003, 41:1690-6. 10.1016\/s0735-1097(03)00332-2","journal-title":"J Am Coll Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof P","year":"2020","unstructured":"Kirchhof P, Camm AJ, Goette A, et al.. Early rhythm-control therapy in patients with atrial fibrillation. N Engl J Med. 2020, 383:1305-16. 10.1056\/NEJMoa2019422","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2029554","article-title":"Cryoballoon ablation as initial therapy for atrial fibrillation","volume":"384","author":"Wazni OM","year":"2021","unstructured":"Wazni OM, Dandamudi G, Sood N, et al.. Cryoballoon ablation as initial therapy for atrial fibrillation. N Engl J Med. 2021, 384:316-24. 10.1056\/NEJMoa2029554","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.84.2.527","article-title":"Stroke prevention in atrial fibrillation study. Final results","volume":"84","author":"SPAF Investigators","year":"1991","unstructured":"SPAF Investigators. Stroke prevention in atrial fibrillation study. Final results. Circulation. 1991, 84:527-39. 10.1161\/01.cir.84.2.527","journal-title":"Circulation"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly SJ","year":"2011","unstructured":"Connolly SJ, Eikelboom J, Joyner C, et al.. Apixaban in patients with atrial fibrillation. N Engl J Med. 2011, 364:806-17. 10.1056\/NEJMoa1007432","journal-title":"N Engl J Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/54036-evolution-of-knowledge-in-the-treatment-of-long-standing-atrial-fibrillation-in-a-uk-tennis-champion","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:30:20Z","timestamp":1707507020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/54036-evolution-of-knowledge-in-the-treatment-of-long-standing-atrial-fibrillation-in-a-uk-tennis-champion"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,22]]},"references-count":18,"URL":"https:\/\/doi.org\/10.7759\/cureus.14624","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,22]]}}}